Serge Rivest on TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer's disease.
COMMENT Here the authors did a systematic analysis of Toll-like receptor (TLR) gene expression in the brains of AD patients versus controls and they found a significant increase in specific members of this family, including TLR2, 4, and 5. To explore the role of ...